Purple Biotech Stock Analysis
| PPBT Stock | USD 0.62 0.12 16.22% |
Purple Biotech is overvalued with Real Value of 0.53 and Hype Value of 0.62. The main objective of Purple Biotech stock analysis is to determine its intrinsic value, which is an estimate of what Purple Biotech is worth, separate from its market price. There are two main types of Purple Biotech's stock analysis: fundamental analysis and technical analysis.
The Purple Biotech stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Purple Biotech is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day. Purple Stock trading window is adjusted to America/New York timezone.
Purple |
Purple Stock Analysis Notes
The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Purple Biotech recorded a loss per share of 0.79. The entity last dividend was issued on the 21st of August 2020. The firm had 1:10 split on the 21st of August 2020. Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people. To find out more about Purple Biotech contact the company at 972 3 933 3121 or learn more at https://purple-biotech.com.Purple Biotech Investment Alerts
| Purple Biotech generated a negative expected return over the last 90 days | |
| Purple Biotech has high historical volatility and very poor performance | |
| Purple Biotech has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (19.88 M) with loss before overhead, payroll, taxes, and interest of (120 K). | |
| Purple Biotech currently holds about 36.02 M in cash with (19.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.0, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Purple Biotech Upcoming and Recent Events
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Purple Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 21.09 M.Technical Drivers
As of the 4th of June, Purple Biotech holds the Coefficient Of Variation of (3,531), variance of 47.39, and Risk Adjusted Performance of (0.01). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Purple Biotech, as well as the relationship between them.Purple Biotech Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Purple Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Purple Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Purple Biotech Predictive Daily Indicators
Purple Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Purple Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 48638.33 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.84 | |||
| Day Median Price | 0.66 | |||
| Day Typical Price | 0.65 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (0.12) | |||
| Relative Strength Index | 47.72 |
Purple Biotech Forecast Models
Purple Biotech's time-series forecasting models are one of many Purple Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Purple Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Purple Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Purple Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Purple shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Purple Biotech. By using and applying Purple Stock analysis, traders can create a robust methodology for identifying Purple entry and exit points for their positions.
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Purple Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.